Xlife Sciences AG
SIX:XLS

Watchlist Manager
Xlife Sciences AG Logo
Xlife Sciences AG
SIX:XLS
Watchlist
Price: 29.1 CHF 0.69% Market Closed
Market Cap: 167.1m CHF
Have any thoughts about
Xlife Sciences AG?
Write Note

Wall Street
Price Targets

XLS Price Targets Summary
Xlife Sciences AG

There are no price targets for XLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Xlife Sciences AG Competitors:
Price Targets
INNOVACAP
Innova Captab Ltd
4% Upside
SKAN
SKAN Group AG
26% Upside
RGEN
Repligen Corp
38% Upside
BANB
Bachem Holding AG
22% Upside
DIVISLAB
Divi's Laboratories Ltd
12% Downside
PPGN
PolyPeptide Group AG
17% Upside
CHEMM
Chemometec A/S
18% Upside
688222
HitGen Inc
31% Upside

Revenue
Forecast

Revenue Estimate
Xlife Sciences AG

For the last 3 years the compound annual growth rate for Xlife Sciences AG's revenue is 36%. The projected CAGR for the next 2 years is 47%.

36%
Past Growth
47%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Xlife Sciences AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Xlife Sciences AG

For the last 3 years the compound annual growth rate for Xlife Sciences AG's net income is -11%.

-11%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XLS's stock price target?
Not Available

XLS doesn't have any price targets made by Wall Street professionals.

What is Xlife Sciences AG's Revenue forecast?
Projected CAGR
47%

For the last 3 years the compound annual growth rate for Xlife Sciences AG's revenue is 36%. The projected CAGR for the next 2 years is 47%.

Back to Top